The transcriptional effects and DNA-binding specificities of 17β-estradiol after dimethyldioxirane activation

Carcinogenesis

Volumn 19, Issue 6, 1998, Pages 1127-1132

  Yu, Fu Li ^a   Bender, Wanda ^a   Zheng, Wei Yun ^a   Wang, Mian Ying ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOUBLE STRANDED DNA; ESTRADIOL; OXIDIZING AGENT; SYNTHETIC DNA;

ARTICLE; CARCINOGEN DNA INTERACTION; DNA BINDING; DNA SEQUENCE; DRUG DNA BINDING; HORMONAL CARCINOGENESIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; ESTRADIOL; NUCLEIC ACID SYNTHESIS INHIBITORS; RATS; SPECTRUM ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 0031926511     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.6.1127     Document Type: Article

References (48)

1. Grady,D., Gebretsakid,T., Kerlikowske,K., Ernster,V. and Petitti,D. (1995) Hormone replacement therapy and endometrial cancer: a meta-analysis. Obstet. Gynecol., 85, 304-313.
2. Fisher,B., Costantino,J.P., Redmond,C.K., Fisher,E.R., Wickerham,D.L. and Cronin,W.M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl Cancer Inst., 86, 527-537.
3. Herbst,A.L., Ulfelder,H. and Poskauzer,D.C. (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med., 284, 878-881.
4. Dragan,Y.P., Xu,Y.-D. and Pitot,H.C. (1991) Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Prev. Med., 20, 15-26.
5. Greaves,P., Goionetilleke,R., Nunn,G., Topham,J. and Orton,T. (1993) Two-year carcinogenicity study of tamoxifen in Alderly Park Wistardeprived rats. Cancer Res., 53, 3919-3924.
6. Hard,G.C., Iatropoulos,M.J., Jordan,D., Radi,L., Kaltenberg,O.P., Imondi,A.R. and Williams,G.M. (1993) Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremilene and tamoxifen in female Crl:CD(BR) rats. Cancer Res., 53, 4534-4541.
7. Williams,G.M., Iatropoulos,M.J., Djordjevic,M.D. and Kaltenberg,O.P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in rat. Carcinogenesis, 14, 315-317.
8. Greenberg,E.R., Barnes,A.B., Resseguie,Z., Barrett,J.A., Burnside,S., Lanza,L.L., Neff,R.K., Stevens,M., Young,R.H. and Colton,T. (1984) Breast cancer in mothers given diethylstilbestrol in pregnancy. N. Engl. J. Med., 311, 1391-1398.
9. Harris,R.E., Namboodiri,K.K. and Wynder,E.L. (1992) Breast cancer risk: effects of estrogen replacement therapy and body mass. J. Natl. Cancer Inst., 84, 1575-1582.
10. Toniolo,P.G., Levitz,M., Zeleniuch-Jacquotte,A., Banerjee,S., Koenig,K.L., Shore,R.E., Strax,P. and Pasternack,B.S. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Res., 87, 190-197.
11. Pike,M., Bernstein,L. and Spicer,D. (1993) Exogenous hormones and breast cancer risk. In Neiderhuber,J. (ed.) Current Therapy in Oncology. BC Decker, St Louis, pp. 292-302.
12. Steinberg,K., Smith,S., Thacker,S., and Stroup,D. (1994) Breast-cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology, 5, 415-421.
13. Colditz,G.A., Hankinson,S.E., Hunter,D.J., Willett,W.C., Manson,J.E., Stampfer,M.J., Hennekens,C., Rosner,B. and Speizer,F.E. (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med., 332, 1589-1593.
14. Venn,A., Watson,L., Lumley,J., Giles,G., King,C. and Healy,D. (1995). Beast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet, 346, 995-1000.
15. Li,J.J. and Li,S.A. (1990) Estrogen carcinogenesis in hamster tissues: a critical review. Endocrine Rev., 11, 524-531.
16. Wanless,I.R. and Medline,A. (1982) The role of estrogens as promoters of hepatic neoplasia. Lab. Invest., 46, 313-320.
17. Yu,F.L. and Bender,W. (1996) Activation of 17-estradiol and estrone by dimethyldioxirane and inhibition of rat liver nuclear and nucleolar RNA synthesis in vitro. Carcinogenesis, 17, 1957-1961.
18. Miller,E.C. and Miller,J.A. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47, 2327-2345.
19. Weisburger,E.K. (1980) Metabolism and activation of chemical carcinogens. Mol. Cell. Biochem., 32, 95-104.
20. Farber,E. (1984) Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A.Clowes memorial lecture. Cancer Res., 44, 5463-5474.
21. Dipple,A. (1995) DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437-441.
22. 32P-post-labelling test for DNA damage. Proc. Natl Acad. Sci. USA, 78, 6126-6129.
23. Harris,C.C. (1991) Chemical and physical carcinogenesis: advances and perspective for the 1990s. Cancer Res. (Suppl.), 51, 5023s-5044s.
24. Hemminki,K. (1993) DNA adducts, mutations and cancer. Carcinogenesis, 14, 2007-2012.
25. Busby,W.F. and Wogan,G.N. (1984) Aflatoxins. In Searle,C.E., (ed.) Chemical Carcinogens, 2nd edn, ACS Monograph 182. American Chemical Society, Washington, DC, pp. 945-1136.
26. Yu,F.L. (1983) Preferential binding of aflatoxin B1 to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro. Carcinogenesis, 4, 889-893.
27. Yu,F.L., Dowe,R.J., Geronimo,I.H. and Bender,W. (1986) Evidence for an indirect mechanism of aflatoxin B1 inhibition of rat liver nuclear RNA polymerase II activity in vivo. Carcinogenesis, 7, 253-257.
28. Yu,F.L., Geronimo,I.H., Bender,W. and Permthamsin,J. (1988) Correlation studies between the binding of aflatoxin B1 to the chromatin components and the inhibition of RNA synthesis. Carcinogenesis, 9, 527-532.
29. Yu,F.L., Bender,W. and Geronimo,I.H. (1988) The binding of aflatoxin B1 to rat liver nucleolar proteins and its effect on DNA-dependent RNA synthesis. Carcinogenesis, 9, 533-540.
30. Yu,F.L., Bender,W. and Geronimo,I.H. (1990) Base and sequence specificities of aflatoxin B1 binding to single- and double-stranded DNAs. Carcinogenesis, 11, 475-478.
31. Yu,F.L., Bender,W. and Wu,Z. (1991) Transcriptional effect of aflatoxin B1 on cytosine and/or hypoxanthine containing DNAs. Mol. Cell. Biochem., 103, 1-8.
32. Yu,F.L., Bender,W. and Hutchcroft,A. (1994) Studies on the binding and transcriptional properties of aflatoxin B1-8,9-epoxide. Carcinogenesis, 15, 1737-1741.
33. Yu,F.L., Cahill,J.M., Lipinski,L.J. and Dipple,A. (1996) Effect of aflatoxin B1-8,9-epoxide-DNA adducts on transcription of a SupF gene fragment. Cancer Lett., 109, 77-83.
34. 32P]-post-labeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
35. Adam,W., Chan,Y.Y., Cremer,D., Gauss,J., Scheutzow,D. and Schindler,M. (1987) Spectral and chemical properties of dimethyldioxirane as determined by experiment and abinitio calculations. J. Org. Chem., 52, 2800-2803.
36. Yu,F.L. (1974) Two functional states of the RNA polymerases in rat hepatic nuclear and nucleolar fractions. Nature, 251, 344-346.
37. Yu,F.L. (1975) An improved method for the quantitative isolation of rat liver nuclear RNA polymerases. Biochim. Biophys. Acta, 395, 329-336.
38. Li,D.H., Wang,M.Y., Dhingra,K. and Hittelman,W.N. (1996) Aromatic DNA adducts in the adjacent tissues of breast cancer patiets: clues to breast cancer etiology. Cancer Res., 56, 287-293.
39. Wang,M.Y. and Liehr,J.G. (1995) Lipid hydroproxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch. Biochem. Biophys., 316, 38-46.
40. Dao,T.L. (1981) The role of ovarian steriod hormones in mammary carcinogenesis. In Pike,M.C., Siiteri,P.K. and Welsch,C.W. (eds) Hormones and Breast Cancer (Banbury Report No. 8). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 281-295.
41. Kirkman,H. (1959) Estrogen-induced tumors of the kidney in the Syrian Hamster. Natl Cancer Inst. Monogr., 1, 1-58.
42. Leihr,J.G. and Roy,D. (1990) Free radical generation by redox cycling of estrogens. Free Rad. Biol. Med., 8, 415-423.
43. Yager,J.D. and Liehr,J.G. (1996) Molecular mechanisms of estrogen carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 36, 203-232.
44. Baertschi,S.W., Raney,K.D., Stone,M.P. and Harris,T.M. (1988) Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species. J. Am. Chem. Soc., 110, 7929-7931.
45. Raney,K.D., Coles,B., Guengerich,F.P. and Harris,T.M. (1992) The endo-8,9-epoxide of aflatoxin B1: a new metabolite. Chem. Res. Toxicol., 5, 333-335.
46. Lyer,R.S., Cole,B.F., Raney,K.D., Thier,R., Guengerich,F.P. and Harris,T.M. (1994) DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies. J. Am. Chem. Soc., 116, 1603-1609.
47. Park,K.K., Surh,Y.J., Stewart,B.C. and Miller,J.A. (1990) Synthesis and properties of vinyl-carbamate epoxide, a possible ultimate electrophilic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate. Biochem. Biophys. Res. Commun., 169, 1094-1098.
48. Park,K.K., Sohn,Y., Liem,A., Kim,H.J., Stewart,B.C. and Miller,J.A. (1997) The electrophilic and tumorigenic activaties of phenyl and 4-nitrophenyl vinyl ethers and their epoxide metabolites. Carcinogenesis, 18, 431-437.